Systematic review Domestic animal endocrinology · 2026 Metabolic and endocrine modulation of the gut-adipose tissue axis via pro-, pre-, and postbiotics in overweight dogs: A systematic review. Southwell M, Faraco M, Ruíz MJ, et al. Akkermansia muciniphilaBifidobacterium animalisBifidobacterium breveEnterococcus faecium PubMed ↗
Randomized trial Cancer prevention research · 2026 Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk. Cook KL, Giles ED, Sekela JJ, et al. Alistipes putredinisPhocaeicola vulgatus PubMed ↗
Review Medicina · 2026 Gut Microbiota in Metabolic Syndrome: Differences in Microbial Signatures and Clinical Profiles. Scarlata GGM, Belančić A, Scarpellini E, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Nutrients · 2026 Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial. Ermolenko E, Sitkin S, Alferova L, et al. Bacteroides fragilisEnterococcus faecium PubMed ↗
Observational Journal of applied microbiology · 2026 Multi-omics analysis identify novel microbiome-metabolome signatures associated with obesity. Tian B, Liu Y, Su KJ, et al. Bacteroides fragilisVeillonella dispar PubMed ↗
Randomized trial Clinical nutrition ESPEN · 2026 Effect of continuous energy restriction combined with probiotic supplementation on parameters related to homeostatic and hedonic systems of food intake in adult men living with obesity: Data from a randomized, parallel, double-blind, placebo-controlled clinical trial. Lucin GA, Marques CG, Magalhães ACO, et al. Bifidobacterium animalis PubMed ↗
Observational Journal of applied microbiology · 2026 Gut species Porphyromonas asaccharolytica and Bacteroides fragilis are associated with whole body fat percentage. Tian B, Liu Y, Su KJ, et al. Bacteroides fragilis PubMed ↗
Randomized trial Cancer reports · 2026 Dance and Dietary Intervention Improves Metabolic Health, Fitness, and Quality of Life With Modest Gut Microbiota Shifts in Breast Cancer Patients With Obesity: A Pilot RCT. Nechalová L, Penesová A, Hric I, et al. Faecalibacterium prausnitziiRuminococcus bromii PubMed ↗
Randomized trial Obesity · 2026 Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial. Baeuerle E, Semwal MK, Nie J, et al. Bifidobacterium longum PubMed ↗
Randomized trial Nature medicine · 2026 Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Mount S, Canfora EE, Jocken JW, et al. Akkermansia muciniphila PubMed ↗
Review JAMA · 2026 Obesity and Cancer: A Translational Science Review. Shen S, Brown KA, Green AK, et al. Akkermansia muciniphila PubMed ↗
Randomized trial Food research international · 2026 Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiota. Wang L, Liang C, Yu J, et al. Akkermansia muciniphila PubMed ↗
Review Letters in applied microbiology · 2026 Anti-obesity effects of probiotics beyond BMI: a critical review of human clinical trials. Athapaththu HAD, Dey G Bifidobacterium breveLactobacillus gasseri PubMed ↗
Review Microbial pathogenesis · 2026 Understanding gut microbiota dysbiosis as a plausible link between obstructive sleep apnea (OSA), viral infections, and lifestyle diseases. Karthik S S, Jadhav P, Paul A, et al. Akkermansia muciniphilaFaecalibacterium prausnitzii PubMed ↗
Observational Gut microbes · 2026 Parasutterella excrementihominis is associated with attenuated metabolic improvements during obesity therapy in humans. Liu S, Schlicht K, Beckmann A, et al. Parasutterella excrementihominis PubMed ↗
Observational Journal of gastroenterology · 2026 Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment. Hayashi T, Iida N, Yasuda K, et al. Escherichia coli PubMed ↗
Observational mSystems · 2026 Gut microbiome signatures associated with depression and obesity. Mora-Martínez C, Molina-Mendoza G, Cenit MC, et al. Faecalibacterium prausnitzii PubMed ↗
Randomized trial Journal of the American Nutrition Association · 2026 Supplementation With Lactococcus lactis LMG 27352: Lack of Beneficial Effects on Cardiometabolic Risk in Obese Patients Without Concomitant Dietary Intervention-A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Morais MA, Sousa BA, Lima de Oiveira JP, et al. Lactococcus lactis PubMed ↗
Randomized trial Diabetes care · 2026 Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial. Li L, Li R, Qiu Z, et al. Bifidobacterium adolescentisRuminococcus callidus PubMed ↗
Randomized trial Clinical nutrition · 2025 Effects of a novel synbiotic intervention on abdominal visceral fat reductions and gut microbiota in overweight and obese adults: A randomized, double-blind, placebo-controlled trial. Li N, Zhu Z, Wu S, et al. Bifidobacterium animalis PubMed ↗